Pressemitteilung BoxID: 493999 (aap Implantate AG)
  • aap Implantate AG
  • Lorenzweg 5
  • 12099 Berlin
  • Ansprechpartner
  • Marc Heydrich
  • +49 (30) 75019-134

aap signs bone cement supply agreement for US market

(lifePR) (Berlin, ) aap gives notice that its subsidiary aap Biomaterials GmbH signed a supply agreement for a PMMA bone cement with a leading US healthcare service provider. Under the terms of the agreement aap's new US partner will market our bone cement, which is mainly used for joint replacements, under its own label.

The supply agreement applies for the United States, Canada and Puerto Rico and has a three-year term with a renewal option.

With the signing of the supply agreement aap Biomaterials GmbH is further extending its leading position in the bone cement sector, emphasising our positive outlook for the financial year 2014.

aap plans to publish its full quarterly report for Q2/2014 on August 14, 2014.

Forward-looking statement

This release may contain forward-looking statements based on current experience, estimates and projections of the management board and currently available information. They are not guarantees of future performance. Various known and unknown risks, uncertainties and other factors could lead to material differences between the actual future results, financial situation, development or performance of the company and the estimates given here. Many factors could cause the actual results, performance or achievements of aap to be materially different from those that may be expressed or implied by such statements. These factors include those discussed in aap's public reports. Forward-looking statements therefore speak only as of the date they are made. aap does not assume any obligation to update the forward-looking statements contained in this release or to conform them to future events or developments.

aap Implantate AG

aap is a global medical device company headquartered in Berlin, Germany that develops, manufactures and markets innovative biomaterials and implants that are used in orthopedic procedures. The Company's products, which include a full line of plating systems, cannulated screws and bone cement products, are primarily used in the orthopedic specialty areas of trauma and spine repair. The Company's products are sold through its direct sales force, distribution partners and license agreements with OEM partners. aap's stock is listed in the Prime Standard segment of the Frankfurt Stock Exchange. For more information, please visit, or download the Company's investor relations app from the Apple's App Store or Google Play.